The Potential of Kava in Enabling Tobacco Cessation - Its Holistic Effects in Managing Stress and Insomnia Associated With Abstinence

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 6, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

Smoking

Interventions

DRUG

Placebo

Participants on this arm will take one placebo capsule orally three times daily for 4 weeks.

DRUG

AB-free kava

Participants on this arm will take one kava capsule (each capsule contains 75 mg of kavalactones) orally three times daily for 4 weeks.

Trial Locations (1)

RECRUITING

University of Florida, Gainesville

All Listed Sponsors

collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

collaborator

National Institutes of Health (NIH)

NIH

lead

University of Florida

OTHER